Where does Praxis Biotech LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Praxis Biotech LLC ranks #49,717 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Praxis Biotech LLC hold?

Praxis Biotech LLC holds 5 US utility patents granted between 2021 and 2023, spanning 6 technology areas.

What is Praxis Biotech LLC's Innovation Score?

Praxis Biotech LLC has an Innovation Score of 49.9 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Praxis Biotech LLC focus on?

Praxis Biotech LLC's top technology area is C07D (Heterocyclic Compounds) with 5 patents, ranking #1,402 of 3,165 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Praxis Biotech LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Praxis Biotech LLC.

What does claim depth mean for Praxis Biotech LLC's patents?

Praxis Biotech LLC's patents average 39.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Praxis Biotech LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Praxis Biotech LLC

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Praxis ranks #49,717 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#49,717
of 49,997 US assignees by volume: Top 14%
by Innovation Score (49.9/100): 39.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49717 · US Corporation #49,717 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,717/49,997
PHOTO-FINISH Powis Parker
CPC-NARROW C07D · 6 areas
INNOV-PAR 49.9/100
CLAIMS-DENSE 39.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Powis Parker Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Praxis’s 49.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (12%) Velocity 20.0 pts (40%) Breadth 8.7 pts (17%) Claim depth 15.0 pts (30%)

Qualcomm Incorporated · highest

85
Praxis Biotech · this assignee

50
3D Lighting… · lowest

7

What this shows Praxis's Innovation Score is 49.9/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Praxis?

Each dot is one of Praxis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Praxis’s own 39.6 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Praxis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Praxis's grants concentrate

Praxis Biotech LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, Praxis sits between Powis Parker Inc. and Precisionhawk, Inc..

Praxis's three-year grant acceleration

Praxis Biotech LLC shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Powis Parker

5
PPG Europe B V

5
PPM Holdings

5
Pramet Tools S R O

5
Prayon

5
Preceyes B V

5
Preciosa A S

5
Precisionhawk

5
Praxis Biotech ◀

5

What this shows Praxis holds 5 patents at rank #49,573, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Praxis

By rank, the assignees closest to #49,573 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Praxis's primary technology class.

Praxis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Praxis Biotech LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2022	3	60.0%
2023	1	20.0%

Which technologies does Praxis Biotech LLC patent most?

C07D - Heterocyclic Compounds 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07K - Peptides 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Praxis Biotech LLC's patent record in context - here's where to go next.

Praxis Biotech LLC's lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #49,717 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Praxis Biotech LLC against Powis Parker Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.